Cargando…
Suppression of Pathological Ocular Neovascularization by a Small Molecular Multi-Targeting Kinase Inhibitor, DCZ19903
PURPOSE: The administration of anti-vascular endothelial growth factor agents is the standard firs-line therapy for ocular vascular diseases, but some patients still have poor outcomes and drug resistance. This study investigated the role of DCZ19903, a small molecule multitarget kinase inhibitor, i...
Autores principales: | Ding, Jingjuan, Li, Bo, Zhang, Huiying, Xu, Zhijian, Zhang, Qiuyang, Ye, Rong, Feng, Siguo, Jiang, Qin, Zhu, Weiliang, Yan, Biao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Association for Research in Vision and Ophthalmology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9749868/ https://www.ncbi.nlm.nih.gov/pubmed/36484641 http://dx.doi.org/10.1167/tvst.11.12.8 |
Ejemplares similares
-
DCZ19931, a novel multi-targeting kinase inhibitor, inhibits ocular neovascularization
por: Zhang, Huiying, et al.
Publicado: (2022) -
Irisin Attenuates Pathological Neovascularization in Oxygen-Induced Retinopathy Mice
por: Zhang, Jieqiong, et al.
Publicado: (2022) -
Immunosubunit β5i Knockout Suppresses Neovascularization and Restores Autophagy in Retinal Neovascularization by Targeting ATG5 for Degradation
por: Ji, Liyang, et al.
Publicado: (2020) -
Fursultiamine Alleviates Choroidal Neovascularization by Suppressing Inflammation and Metabolic Reprogramming
por: Do, Ji Yeon, et al.
Publicado: (2020) -
Aqueous Fluid Transcriptome Profiling Differentiates Between Non-Neovascular and Neovascular AMD
por: Kaidonis, Georgia, et al.
Publicado: (2023)